Skip to main content
S&P 5007,773.95+0.66%DOW51,267.90+0.18%NASDAQ27,477.31+1.05%BTC$85,823.00-0.87%ETH$2,714.23-0.50%GOLD$4,166.20+0.23%OIL$89.41-0.02%
Smart Investors Daily
SID Premium
Baxter International Inc. logo

NYSE · BAX

Baxter International Inc.

Healthcare · Medical - Instruments & Supplies

$24.22

Up+$0.73 (+3.11%)

Updated Oct 6, 2026, 7:33 AM

SID Score

5.7/10

Composite research score

Smart Money

47/100

Neutral

Market cap
9.71B
P/E ratio
-28.49
Dividend yield
2.15%
52-week range
$15.73 – $30.00
Volume
10.16M
Avg. volume
7.88M

Price performance · BAX

BAX price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Oct 5, 2026

BAX closed at $24.22 after 20 trading sessions, down 2.57% for the selected period.

Last close
$24.22
Period change
-2.57%
Period low
$22.80
Period high
$24.86
Daily close
View OHLC price history
BAX OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 5, 2026$23.46$24.285$23.235$24.2210.16M
Oct 2, 2026$23.84$23.85$23.40$23.494.81M
Oct 1, 2026$23.95$24.04$23.48$23.647.38M
Sep 30, 2026$23.50$24.095$23.365$24.008.73M
Sep 29, 2026$23.29$23.72$23.145$23.486.69M
Sep 28, 2026$23.21$23.82$23.11$23.496.17M
Sep 25, 2026$23.43$23.705$23.20$23.376.57M
Sep 24, 2026$23.48$23.76$23.20$23.487.35M
Sep 23, 2026$23.59$24.30$23.45$23.499.44M
Sep 22, 2026$23.21$23.865$23.21$23.687.36M
Sep 21, 2026$22.99$23.08$22.56$22.9311.75M
Sep 18, 2026$23.05$23.155$22.7111$22.809.97M
Sep 17, 2026$23.70$23.735$22.98$23.026.62M
Sep 16, 2026$23.76$23.865$23.18$23.539.45M
Sep 15, 2026$23.94$23.94$23.16$23.716.15M
Sep 14, 2026$24.01$24.2179$23.605$23.865.74M
Sep 11, 2026$24.65$24.77$23.665$23.805.45M
Sep 10, 2026$24.15$24.375$23.9238$24.185.75M
Sep 9, 2026$24.71$25.205$24.39$24.395.3M
Sep 8, 2026$25.59$25.75$24.66$24.865.91M

Latest BAX news

The latest Smart Investors Daily articles mentioning BAX.

Stock researchCompany · Overview

BAX research

Overview

Company profile and research snapshot.

Company profile

Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$23.80
Implied upside
—
Analysts
—
BAX recent ratings
DateFirmRatingTarget
Oct 5, 2026CitigroupNeutral—
Jul 31, 2026TD CowenHold—
Jul 31, 2026Wells FargoEqual-Weight—
Jul 31, 2026StifelHold—
Jul 31, 2026CitigroupNeutral—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 30, 2026

What Investors Might Be Missing On Baxter International (BAX)

Baxter International (BAX) has drawn fresh attention after publishing its 2026 Connected Hospital Report, spotlighting how U.S. hospitals are using technology maturity benchmarks to pursue operational efficiency, workflow automation, and data integration priorities. Baxter International’s recent Connected Hospital Report lands after a mixed run in the stock, with the share price up 20.41% year to date and 8.25% over 90 days but down 10.14% over the past month. Total shareholder return sits at...

Yahoo · Sep 30, 2026

Baxter Releases Inaugural Connected Hospital Report

DEERFIELD, Ill., September 30, 2026--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced the release of its 2026 Connected Hospital Report, offering new insights into how hospitals across the United States are leveraging technology investments to drive clinical and operational outcomes.

Yahoo · Sep 28, 2026

Global Remote Cardiac Monitoring Market Size, Share & Trends Analysis 2026-2036 Featuring Profiles of Medtronic, Abbott Labs, Boston Scientific, GE HealthCare Technologies, Philips, Baxter International (Hillrom) and Other Key Players

Growth is driven by rising cardiovascular disease, telehealth adoption, and advances in wearable ECG devices, implantable monitors, AI analytics, and cloud platforms. North America leads, while Asia-Pacific is expected to grow fastest.Dublin, Sept. 28, 2026 (GLOBE NEWSWIRE) -- "Remote Cardiac Monitoring Market Size, Share & Trends Analysis - Global Opportunity Analysis and Industry Forecast (2026-2036)" has been added to ResearchAndMarkets.com's offering.The global Remote Cardiac Monitoring Mark

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By